Yeh J-J, Hsu N-Y, Hsu W-H, Tsai C-H, Lin C-C, Liang J-A
Department of Thoracic Medicine, Ping Tung Christian Hospital, and Mei Ho Institute of Technology, Ping Tung, Taiwan.
Lung. 2005 May-Jun;183(3):177-83. doi: 10.1007/s00408-004-2532-1.
The aim of this study was to investigate the expression of P-glycoprotein (Pgp), multidrug resistance-related protein-1 (MRP1), and lung resistance-related protein (LRP) in response to chemotherapy in untreated small cell lung cancer (SCLC). Immunohistochemical analyses were performed on multiple nonconsecutive sections of biopsy specimens to detect Pgp, MRP1, and LRP expression in 40 patients with SCLC before chemotherapeutic induction. Response to chemotherapy was evaluated by clinical and radiological methods. The patients were divided into a good response group (n = 20) and a poor response group (n = 20). No significant differences in prognostic factors (Karnofsky performance status, tumor size, or tumor stage) were found between the two groups of patients. The difference in positive Pgp and MRP1 expressions between the good and poor response groups was significant. However, the difference in LRP expression was not significant. We conclude that chemotherapy response of patients with SCLC was related to either Pgp or MRP1 but not LPR expression.
本研究旨在调查未经治疗的小细胞肺癌(SCLC)中P-糖蛋白(Pgp)、多药耐药相关蛋白1(MRP1)和肺耐药相关蛋白(LRP)在化疗反应中的表达情况。对活检标本的多个非连续切片进行免疫组织化学分析,以检测40例SCLC患者化疗诱导前Pgp、MRP1和LRP的表达。通过临床和影像学方法评估化疗反应。将患者分为良好反应组(n = 20)和不良反应组(n = 20)。两组患者在预后因素(卡诺夫斯基功能状态、肿瘤大小或肿瘤分期)方面未发现显著差异。良好反应组和不良反应组之间Pgp和MRP1阳性表达的差异具有统计学意义。然而,LRP表达的差异不显著。我们得出结论,SCLC患者的化疗反应与Pgp或MRP1有关,而与LPR表达无关。